Abstract:Objective: To enquire into the clinical significance and potential molecular mechanism of microRNA (miRNA)-196b-5p in hepatocellular carcinoma (HCC). Methods: Quantitative reverse transcription and polymerase chain reaction (qRT-PCR) were utilized to examine miR-196b-5p expression level in 67 HCC paraffin embedded tissues and corresponding adjacent tissues. Correlations of miR-196b-5p expression level with clinicopathological characteristics were analyzed in our study. The expression level and clinical significance of miR-196b-5p in HCC were also evaluated in The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. We made predictions of the target genes of miR-196b-5p by twelve online software and then selected genes predicted by at least 5 software. Subsequently, in order to obtain the potential target genes of miR-196b-5p, we overlapped the predicted target genes and down-regulated mRNAs in HCC based on TCGA database. Then, we performed the Gene Ontology (GO) and the Disease Ontology (DO) functional annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and Protein-Protein Interaction (PPI) network construction of those miR-196b-5p potential target genes. Results: Higher expression level of miR-196b-5p was seen in HCC tissues than in the corresponding adjacent tissues based on qRT-PCR (P = 0.0007). The expression level of miR-196b-5p was linked with tumor size (P = 0.03), tumor node (P = 0.024), vascular invasion (P = 0.029) and capsular invasion (P = 0.026) in HCC patients. Comprehensive meta-analysis of miR-196b-5p expression based on TCGA, GEO and qRT-PCR verified that higher expression level of miR-196b-5p was observed in HCC tissues than in normal control liver tissues (SMD = 0.56, 95%CI: 0.39-0.72, P (heterogeneity) = 0.275, I-2 = 18.3%). GO annotation revealed that the top terms in biological process, cellular component and molecular function were single-organism catabolic process, neuronal cell body and transmembrane receptor protein kinase activity, respectively. The most relevant disease in DO annotation was arteriosclerosis. The tryptophan metabolism pathway ranked first in KEGG pathway enrichment analysis. The PPI network showed that IGF1, FOXO1, AR and FOS were mostly likely to become the core genes of miR-196b-5p potential target genes, which however required further experiments for validation. Conclusion: The miR-196b-5p was observed to show higher expression in HCC tissues than in normal control liver tissues. Moreover, the miR-196b-5p expression level had correlations with the clinicopathological parameters such as vascular invasion of HCC, but the molecular mechanisms of miR-196b-5p in HCC still need further elucidation and verification.

Clinical Significance of High Expression of Mir-452-5p in Lung Squamous Cell Carcinoma.

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Clinical Value of Mir-182-5p in Lung Squamous Cell Carcinoma: a Study Combining Data from TCGA, GEO, and RT-qPCR Validation

Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases

Identification of Stage-associated MicroRNAs in Lung Adenocarcinoma Based on Microarray Data

Identification Of Mir-133a-3p-Expression Signature And Probable Mechanism In Lung Squamous Cell Carcinoma: Insights From Integrated Analysis

Clinical Value and Potential Mechanism of Mirna-33A-5p in Lung Squamous Cell Carcinoma

Downregulation of Mir-125B-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma.

Investigation of Mir-136-5p Key Target Genes and Pathways in Lung Squamous Cell Cancer Based on TCGA Database and Bioinformatics Analysis

MiR-452-5 p may serve as an oncogene in colorectal cancer through targeting CDKN 1 B : a study based on bioinformatics analysis and dual-luciferase reporter assay

The Suppressive Role of Mir-542-5p in NSCLC: the Evidence from Clinical Data and in Vivo Validation Using a Chick Chorioallantoic Membrane Model

Down-Regulation of Mir-452 is Associated with Poor Prognosis in the Non-Small-Cell Lung Cancer

Investigation of Targeting Relationship Between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcinoma

The Clinical Significance and Mechanism of Microrna-22-3p Targeting TP53 in Lung Adenocarcinoma.

Clinical Significance of Microrna-196B-5p in Hepatocellular Carcinoma and Its Potential Molecular Mechanism

Up-Regulation Of Mir-182-5p Predicts Poor Prognosis In Patients With Lung Cancer And Associates With Tumor Cell Growth And Migration

A Meta-Analysis And Bioinformatics Exploration Of The Diagnostic Value And Molecular Mechanism Of Mir-193a-5p In Lung Cancer

Mir-550A-5p Functions As a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma

Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis

MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

Clinical Significance of Mir-210 and Its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation Via Real-Time Quantitative PCR.